HCW Biologics Inc.
HCW Biologics Inc. (HCWB) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · HCWB · as of Jun 9, 2026
Activity summary
Buy transactions
12
P-Purchase only
Sell transactions
0
12 Months
Buy/Sell ratio
∞
Buy/Sell (by trades)
Overall sentiment
HCW Biologics Inc. insiders have been net buyers of shares over the past 12 Months, which may signal confidence in the company's outlook.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 9, 2026
HCWB insider buying and selling by quarter
HCWB insider selling · HCWB insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 9, 2026
Active insiders
Most active in past 12 months · HCWB ceo insider trading
Showing all insiders · Click a card to filter the transactions table below
▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API
Recent insider transactions
HCWB executive sell shares · HCWB board member insider trading · HCWB insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| May 22, 2026 | Wong Hing C CEO · Director | Purchase | 113,879 | $160K | Form 4 |
| May 22, 2026 | GARRETT SCOTT T Director | Purchase | 177,936 | $250K | Form 4 |
| May 22, 2026 | Byam Rebecca CFO | Purchase | 14,235 | $20K | Form 4 |
| May 16, 2025 | Wong Hing C CEO · Director | Purchase | 8,054 | $60K | Form 4 |
| May 16, 2025 | Winer Gary M Director | Purchase | 1,342 | $10K | Form 4 |
| May 16, 2025 | GARRETT SCOTT T Director | Purchase | 13,423 | $100K | Form 4 |
| May 8, 2025 | Winer Gary M Director | Purchase | 2,308 | $60K | Form 4 |
| May 8, 2025 | Wong Hing C CEO · Director | Purchase | 92,500 | $2.40M⚡ | Form 4 |
| May 8, 2025 | GARRETT SCOTT T Director | Purchase | 5,385 | $140K | Form 4 |
| May 8, 2025 | Byam Rebecca CFO | Purchase | 8,462 | $220K | Form 4 |
| May 8, 2025 | Flowers Lee SVP of Business Development | Purchase | 962 | $25K | Form 4 |
| May 8, 2025 | Greene Rick S. Director | Purchase | 962 | $25K | Form 4 |
| Feb 20, 2024 | Wong Hing C CEO · Director | Award | 739,288 | $1.04M⚡ | Form 4 |
| Feb 20, 2024 | Greene Rick S. Director | Award | 35,714 | $50K | Form 4 |
| Feb 20, 2024 | Giles Lisa M. Director | Award | 35,715 | $50K | Form 4 |
| Feb 20, 2024 | GARRETT SCOTT T Director | Award | 142,858 | $200K | Form 4 |
| Feb 20, 2024 | Flowers Lee SVP of Business Development | Award | 71,429 | $100K | Form 4 |
| Feb 20, 2024 | Byam Rebecca CFO | Award | 760,714 | $1.06M⚡ | Form 4 |
| Dec 11, 2023 | Rhode Peter See Remarks | Option | 14,000 | $2K | Form 4 |
| Dec 8, 2023 | Flowers Lee SVP of Business Development | Option | 7,501 | $1K | Form 4 |
| Nov 17, 2023 | Rhode Peter See Remarks | Option | 15,000 | $2K | Form 4 |
| Oct 19, 2023 | Byam Rebecca CFO | Option | 47,249 | $7K | Form 4 |
| Sep 14, 2023 | Wong Hing C CEO · Director | Purchase | 1,800 | $4K | Form 4 |
| Sep 14, 2023 | Winer Gary M Director | Purchase | 879 | $2K | Form 4 |
| Sep 14, 2023 | Winer Gary M Director | Purchase | 162 | $337 | Form 4 |
Wong Hing C
CEO · Director
Date
May 8
Shares
92,500
Price
$26.00
Value
$2.40M ⚡
Flowers Lee
SVP of Business Development
Date
May 8
Shares
962
Price
$26.00
Value
$25K
Flowers Lee
SVP of Business Development
Date
Feb 20
Shares
71,429
Price
$1.40
Value
$100K
Flowers Lee
SVP of Business Development
Date
Dec 8
Shares
7,501
Price
$0.14
Value
$1K
⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About HCWB insider trading
HCWB insider trades
HCW Biologics Inc. (HCWB) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Wong Hing C (CEO · Director), GARRETT SCOTT T (Director), Byam Rebecca (CFO). Over the past 12 months, 3 insiders have filed transactions with the SEC. HCWB insiders have been primarily buying, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For HCW Biologics Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
HCWB insider trading · 5 questionsThe insiders of HCW Biologics Inc. (HCWB) include executives and directors such as Wong Hing C (CEO · Director), GARRETT SCOTT T (Director), Byam Rebecca (CFO), among others. Over the past 12 months, 3 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 9, 2026